Pfizer Inc. and BioNTech SE announced today that the FDA has approved their COVID-19 vaccine for adults ages 65 and older and individuals from 5 to 64 years old who have at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. The approval comes amidst the development of a… The post Pfizer and BioNTech’s COVID vaccine approved for individuals at increased risk appeared first on Drug Discovery and Development.| Drug Discovery and Development